Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novel lysophospholipid S1P1 receptor agonists presented by Sanofi

Aug. 9, 2011

Unigene and GSK enter further agreement for oral PTH analogue

Aug. 9, 2011

Repros Therapeutics reports data from Androxal study in men with type 2 diabetes

Aug. 8, 2011

Palatin Technologies confirms commencement of phase I trial of AZD-2820

Aug. 8, 2011

Pitavastatin is approved in Mexico for hyperlipidemia

Aug. 5, 2011

Development of pramlintide/metreleptin for obesity discontinued

Aug. 5, 2011

FDA grants orphan drug status to Kamada's AAT product in type 1 diabetes

Aug. 5, 2011

Prolor Biotech reports encouraging results from phase II hGH-CTP trial

Aug. 5, 2011

KBP BioSciences presents new dipeptidyl peptidase 4 inhibitors

Aug. 5, 2011

NPS Pharmaceuticals and GSK form new calcilytics agreement

Aug. 4, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...